Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 17 studies | 24% ± 9% | |
endothelial cell | 9 studies | 23% ± 6% | |
type I pneumocyte | 7 studies | 24% ± 8% | |
epithelial cell | 5 studies | 27% ± 9% | |
connective tissue cell | 4 studies | 24% ± 5% | |
myofibroblast cell | 4 studies | 20% ± 4% | |
pericyte | 4 studies | 20% ± 1% | |
mesothelial cell | 4 studies | 24% ± 13% | |
smooth muscle cell | 3 studies | 21% ± 6% | |
abnormal cell | 3 studies | 23% ± 4% | |
glutamatergic neuron | 3 studies | 33% ± 12% | |
basal cell | 3 studies | 28% ± 8% | |
oligodendrocyte precursor cell | 3 studies | 19% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
bladder | 100% | 9203.24 | 21 / 21 | 100% | 92.34 | 504 / 504 |
esophagus | 100% | 10549.42 | 1445 / 1445 | 100% | 84.74 | 183 / 183 |
lung | 100% | 9602.88 | 578 / 578 | 100% | 94.27 | 1155 / 1155 |
ovary | 100% | 10834.26 | 180 / 180 | 100% | 63.28 | 430 / 430 |
breast | 100% | 10537.86 | 459 / 459 | 100% | 92.97 | 1117 / 1118 |
intestine | 100% | 7803.16 | 966 / 966 | 100% | 69.12 | 526 / 527 |
prostate | 100% | 7195.43 | 245 / 245 | 100% | 64.88 | 501 / 502 |
skin | 100% | 14949.62 | 1809 / 1809 | 100% | 87.34 | 470 / 472 |
uterus | 100% | 13471.21 | 170 / 170 | 100% | 88.32 | 457 / 459 |
thymus | 100% | 8328.48 | 652 / 653 | 100% | 130.60 | 602 / 605 |
adrenal gland | 100% | 5357.88 | 257 / 258 | 98% | 45.67 | 225 / 230 |
kidney | 96% | 4169.88 | 85 / 89 | 99% | 104.92 | 894 / 901 |
stomach | 91% | 4703.89 | 326 / 359 | 100% | 69.72 | 285 / 286 |
brain | 83% | 2396.32 | 2197 / 2642 | 100% | 69.46 | 704 / 705 |
pancreas | 79% | 2198.81 | 259 / 328 | 99% | 96.81 | 176 / 178 |
liver | 44% | 980.15 | 100 / 226 | 73% | 25.89 | 297 / 406 |
adipose | 100% | 11749.19 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 16534.10 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 41.39 | 29 / 29 |
spleen | 100% | 5132.24 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 93.99 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 59.18 | 1 / 1 |
heart | 96% | 6118.45 | 828 / 861 | 0% | 0 | 0 / 0 |
muscle | 96% | 5782.19 | 768 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 91% | 37.15 | 73 / 80 |
peripheral blood | 81% | 4044.65 | 750 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006629 | Biological process | lipid metabolic process |
GO_0071763 | Biological process | nuclear membrane organization |
GO_0045087 | Biological process | innate immune response |
GO_0005788 | Cellular component | endoplasmic reticulum lumen |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0005886 | Cellular component | plasma membrane |
GO_0005637 | Cellular component | nuclear inner membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0042802 | Molecular function | identical protein binding |
GO_0005515 | Molecular function | protein binding |
Gene name | TMEM43 |
Protein name | Transmembrane protein 43 isoform 2 Transmembrane protein 43 Transmembrane protein 43 (Protein LUMA) Transmembrane protein 43 isoform 1 (Transmembrane protein 43, isoform CRA_a) |
Synonyms | UNQ2564/PRO6244 hCG_27238 |
Description | FUNCTION: May have an important role in maintaining nuclear envelope structure by organizing protein complexes at the inner nuclear membrane. Required for retaining emerin at the inner nuclear membrane (By similarity). Plays a role in the modulation of innate immune signaling through the cGAS-STING pathway by interacting with RNF26 . In addition, functions as a critical signaling component in mediating NF-kappa-B activation by acting downstream of EGFR and upstream of CARD10 . Contributes to passive conductance current in cochlear glia-like supporting cells, mediated by gap junctions and necessary for hearing and speech discrimination . . |
Accessions | A0A024R2F9 Q9BTV4 A0A0S2Z5N2 F8WDL3 ENST00000306077.5 ENST00000432444.2 |